000			01391 a2200397 4500
005			20250512131651.0
264		0	_c19680216
008			196802s 0 0 eng d
022			_a0028-7113
024	7		_a10.1111/j.2164-0947.1967.tb02428.x _2doi
040			_aNLM _beng _cNLM
100	1		_aYoung, L S
245	0	0	_aGentamicin in the treatment of severe, hospital-acquired gram-negative infections. _h[electronic resource]
260			_bTransactions of the New York Academy of Sciences _cMar 1967
300			_a579-88 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCross Infection _xdrug therapy
650	0	4	_aEscherichia coli Infections _xdrug therapy
650	0	4	_aFemale
650	0	4	_aGentamicins _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aKlebsiella Infections _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProteus Infections _xdrug therapy
650	0	4	_aPseudomonas Infections _xdrug therapy
650	0	4	_aStaphylococcal Infections _xdrug therapy
700	1		_aLouria, D B
700	1		_aArmstrong, D
773	0		_tTransactions of the New York Academy of Sciences _gvol. 29 _gno. 5 _gp. 579-88
856	4	0	_uhttps://doi.org/10.1111/j.2164-0947.1967.tb02428.x _zAvailable from publisher's website
999			_c4867744 _d4867744